Product Information

POTASSIUM CITRATE ER 10 MEQ TB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1798 per EA under NDC 68382053701. Its NADAC has been published 623 times since Sep 17, 2014.

FDA first approved this application on Aug 6, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 10 MEQ TB

Potassium Citrate
$0.1798per EA

Strength

10 meq/1

NDC

68382053701

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203546

FDA Approved

8/6/2014

TE Code

AB

On Market Since

8/12/2014

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 10 MEQ TB has been published 623 times since Sep 17, 2014, and over the history we have for it it has declined 86.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1798 per EA
All-time high$1.3386 (Oct 15, 2014)
All-time low$0.1666 (Sep 17, 2025)
52-week high$0.1831
52-week low$0.1666
Median price$0.4872
Average price$0.6227
Largest weekly change-36.0% (Sep 23, 2020)
Weeks tracked623
Tracking sinceSep 17, 2014

Price History

1W

-0.8%

1M

-0.8%

3M

+0.8%

6M

+3.9%

1Y

-1.8%

3Y

-32.4%

5Y

-43.3%

All

-86.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 10 MEQ TB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 10 MEQ TB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1798 per EA (NDC 68382053701), effective Aug 19, 2026.

How has the price of POTASSIUM CITRATE ER 10 MEQ TB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has declined 86.6%. It has been tracked across 623 weekly CMS publications since Sep 17, 2014.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 10 MEQ TB?

Since Sep 17, 2014, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has ranged from a low of $0.1666 (Sep 17, 2025) to a high of $1.3386 (Oct 15, 2014), with a median of $0.4872 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 10 MEQ TB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 10 MEQ TB in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CITRATE ER 10 MEQ TB?

POTASSIUM CITRATE ER 10 MEQ TB (NDC 68382053701) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.